Similar articles

• Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin.

  Misbin RI. Misbin RI. N Engl J Med. 2023 Oct 19;389(16):1532-1533. doi: 10.1056/NEJMc2310221. N Engl J Med. 2023. PMID: 37851883 No abstract available.
• Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin.

  Rosenstock J, Bain SC, Gowda A, Jódar E, Liang B, Lingvay I, Nishida T, Trevisan R, Mosenzon O; ONWARDS 1 Trial Investigators. Rosenstock J, et al. N Engl J Med. 2023 Jul 27;389(4):297-308. doi: 10.1056/NEJMoa2303208. Epub 2023 Jun 24. N Engl J Med. 2023. PMID: 37356066 Clinical Trial.
• Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin. Reply.

  Rosenstock J, Gowda A, Liang B. Rosenstock J, et al. N Engl J Med. 2023 Oct 19;389(16):1533. doi: 10.1056/NEJMc2310221. N Engl J Med. 2023. PMID: 37851884 No abstract available.
• Insulin icodec: A novel once-weekly treatment for diabetes.

  Schaffner H, Wiener J, DeLuca A, Genovese A, Deeb A, Deeb W, Sheikh-Ali M, Sutton D, Gore A, Berner J, Huston J, Goldfaden R. Schaffner H, et al. Diabet Med. 2024 Oct;41(10):e15414. doi: 10.1111/dme.15414. Epub 2024 Jul 24. Diabet Med. 2024. PMID: 39046097 Review.
• Once-Weekly Insulin Icodec vs. Once-Daily Insulin Glargine U100 for type 2 diabetes: a systematic review and meta-analysis of phase 2 randomized controlled trials.

  Ribeiro E Silva R, de Miranda Gauza M, Guisso MES, da Silva JON, Kohara SK. Ribeiro E Silva R, et al. Arch Endocrinol Metab. 2023 May 25;67(5):e000614. doi: 10.20945/2359-3997000000614. Arch Endocrinol Metab. 2023. PMID: 37249450 Free PMC article.